CRT 2024

Discussion: Is There a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

Panel Moderator(s)

• 

  Alexandre A. Abizaid, MD, PhD

  Director of Invasive Cardiology
  Incor
  SÃO PAULO, Sao Paulo, Brazil

  No relationships to disclose
• 

  Michael H. Joner, MD

  Associate Professor Interventional Cardiology
  Deutsches Herzzentrum Muenchen
  Munich, Bayern, Germany

  No relationships to disclose
• 

  Yoshinobu Onuma, MD, PhD

  Professor of Interventional Cardiology
  University of Galway
  Galway, Galway, Ireland

  No relationships to disclose

Panel Discussant(s)

• SB

  Sandeep Basavarajaiah, MD

  No relationships to disclose
• 

  David Erlinge, MD, PhD

  Professor, Consultant Interventional Cardiology
  Lund University
  Lund, Sweden

  No relationships to disclose
• 

  Michael Haude, MD, PhD

  Director of the Heart & Vascular Center
  Rheinland Klinikum Neuss GmbH
  Neuss, Germany

  Disclosure information not submitted.
• 

  Semih Oktay, PhD

  President
  Cardiomed Device Consultants
  Annapolis, Maryland, United States

  No relationships to disclose
• 

  Sahil A. Parikh, MD, FSCAI

  Associate Professor of Medicine
  Columbia University Vagelos College of Physicians and Surgeons
  New York, New York, United States

  No relationships to disclose
• 

  Richard J. Rapoza, PhD

  Divisional Vice President, Global Research and Development
  Abbott Vascular
  Santa Clara, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Pieter C. Smits, PhD, FESC

  Medical Director
  CERC (Cardiovascular European Research Center)
  Rotterdam, Zuid-Holland, Netherlands

  No relationships to disclose
• 

  Ruben Yannick Gerold Tijssen, MD, PhD

  MD, PhD
  St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam
  Naarden, Noord-Holland, Netherlands

  No relationships to disclose